Peer-Reviewed Technical Note: Influence of Common Excipients on the Crystalline Modification of Freeze-Dried Mannitol - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Peer-Reviewed Technical Note: Influence of Common Excipients on the Crystalline Modification of Freeze-Dried Mannitol


Pharmaceutical Technology
Volume 3, Issue 32

References

1. M. J. Pikal, "Freeze Drying," Encyclopedia of Pharmaceutical Technology (Marcel Dekker, New York, 2002), pp. 1299–1326.

2. R.K. Cavatur et al., "Crystallization Behavior of Mannitol in Frozen Aqueous Solutions," Pharm. Res. 19 (6), 894–900 (2002).

3. X. Liao et al., "Influence of Processing Conditions on the Physical State of Mannitol—Implications in Freeze-Drying," Pharm. Res. 24 (2), 370–376 (2007).

4. A.I. Kim et al., "The Physical State of Mannitol after Freeze-Drying: Effects of Mannitol Concentration, Freezing Rate, and a NonCrystallizing Cosolute," J. Pharm. Sci., 87 (8), 931–935 (1998).

5. A. Burger et al., "Energy/Temperature Diagram and Compression Behavior of the Polymorphs of D-Mannitol," J. Pharm. Sci. 89 (4), 457–468 (2000).

6. C. Telang et al., "Crystallization of D-Mannitol in Binary Mixtures with NaCl: Phase Diagram and Polymorphism," Pharm. Res. 20 (12), 1939–1945 (2003).

7. J. Liu, "Physical Characterization of Pharmaceutical Formulations in Frozen and Freeze-Dried Solid States: Techniques and Applications in Freeze-Drying Development," Pharm. Dev. Technol. 11 (1), 3–38 (2006).

8. K. Chatterjee et al., "Partially Crystalline Systems in Lyophilization: II. Withstanding Collapse at High Primary Drying Temperatures and Impact on Protein Activity Recovery," J. Pharm. Sci. 94 (4), 809–820 (2005).

9. T. Yoshinari et al., "Moisture Induced Polymorphic Transition of Mannitol and its Morphological Transformation," Int. J. Pharm. 247 (1–2), 69–77 (2002).

10. L. Yu et al., "Existence of a Mannitol Hydrate During Freeze-Drying and Practical Implications," J. Pharm. Sci. 88 (2), 196-198(1999).

11. A. Hawe and W. Friess, "Impact of Freezing Procedure and Annealing on the Physico-Chemical Properties and the Formation of Mannitol Hydrate in Mannitol-Sucrose-NaCl Formulations," Eur J Pharm Biopharm 64 (3), 316–325 (2006).

12. L. Yu et al., "Determination of the Glass Properties of D-Mannitol Using Sorbitol as an Impurity," J. Pharm. Sci. 87 (6), 774–777 (1998).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here